David S Tierney Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

David S Tierney is Director of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 348,874 shares of CPRX, which is worth approximately $7.38 Million. The most recent transaction as insider was on Aug 21, 2024, when has been sold 15,000 shares (Common Stock, par value $0.001 per share) at a price of $20.1 per share, resulting in proceeds of $301,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 349K

0% 3M change

4.6% 12M change

Total Value Held $7.38 Million

David S Tierney Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 21 2024	SELL Open market or private sale	$301,500 $20.1 p/Share	15,000 Reduced 4.12%	348,874 Common Stock, par valu...
Aug 21 2024	BUY Exercise of conversion of derivative security	$60,150 $4.01 p/Share	15,000 Added 3.96%	363,874 Common Stock, par valu...
Apr 08 2024	SELL Open market or private sale	$392,000 $15.68 p/Share	25,000 Reduced 6.69%	348,874 Common Stock, par valu...
Apr 08 2024	BUY Exercise of conversion of derivative security	$100,250 $4.01 p/Share	25,000 Added 6.27%	373,874 Common Stock, par valu...
Feb 15 2024	BUY Exercise of conversion of derivative security	-	4,000 Added 1.13%	348,874 Common Stock, par valu...
Jan 02 2024	BUY Exercise of conversion of derivative security	$11,299 $1.13 p/Share	10,000 Added 2.82%	344,874 Common Stock, par valu...
Dec 27 2023	BUY Exercise of conversion of derivative security	-	1,333 Added 0.4%	334,874 Common Stock, par valu...
Dec 12 2023	SELL Open market or private sale	$666,000 $13.32 p/Share	50,000 Reduced 13.04%	333,541 Common Stock, par valu...
Dec 12 2023	BUY Exercise of conversion of derivative security	$56,499 $1.13 p/Share	50,000 Added 11.53%	383,541 Common Stock, par valu...
May 11 2023	BUY Exercise of conversion of derivative security	$15,800 $0.79 p/Share	20,000 Added 5.66%	333,541 Common Stock, par valu...
Apr 05 2023	SELL Open market or private sale	$504,899 $16.83 p/Share	30,000 Reduced 8.73%	313,541 Common Stock, par valu...
Apr 05 2023	BUY Exercise of conversion of derivative security	$23,700 $0.79 p/Share	30,000 Added 8.03%	343,541 Common Stock, par valu...
Feb 15 2023	BUY Exercise of conversion of derivative security	-	4,000 Added 1.26%	313,541 Common Stock, par valu...
Dec 06 2022	BUY Exercise of conversion of derivative security	-	1,334 Added 0.43%	309,541 Common Stock, par valu...
Aug 22 2022	SELL Open market or private sale	$283,200 $14.16 p/Share	20,000 Reduced 6.09%	308,207 Common Stock, par valu...
Aug 22 2022	BUY Exercise of conversion of derivative security	$50,600 $2.53 p/Share	20,000 Added 5.74%	328,207 Common Stock, par valu...
May 20 2022	SELL Open market or private sale	-	20,000 Reduced 6.09%	308,207 Common Stock, par valu...
May 20 2022	BUY Exercise of conversion of derivative security	$50,600 $2.53 p/Share	20,000 Added 5.74%	328,207 Common Stock, par valu...
Dec 03 2021	BUY Exercise of conversion of derivative security	-	1,333 Added 0.43%	308,207 Common Stock, par valu...
Aug 13 2021	SELL Open market or private sale	$304,000 $6.08 p/Share	50,000 Reduced 14.01%	306,874 Common Stock, par valu...
Aug 13 2021	BUY Exercise of conversion of derivative security	$156,000 $3.12 p/Share	50,000 Added 12.29%	356,874 Common Stock, par valu...
Dec 22 2020	BUY Exercise of conversion of derivative security	-	1,333 Added 0.43%	306,874 Common Stock, par valu...

Also insider at

KMPH

KEMPHARM, INC Healthcare

Director

DST

David S Tierney

Director

Coral Gables, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX

Account